We are holistic in our evaluation and highly targeted in our search for innovative therapeutics that can truly improve patient lives. Where are the biosciences with the potential to transform the outcomes? You'll find us there.
We are lenders of conviction as we seek to invest in companies with the greatest potential to better patient lives.
Speaking the language of both scientist and strategist allows us to engage as thought partners, leading to true symbiosis with our portfolio companies.
We start by vetting for exceptional management, strong science, and rational financing strategies, and then we dig deep.